Physician profile
John C House
NPI 1538138805
$3,654.52
in general payments reported to CMS, 2019-2025
38 companies · $758 in 2025
The $758 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $632 · 2020: $313 · 2021: $277 · 2022: $565 · 2023: $573 · 2024: $537 · 2025: $758.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,868.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,867.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $576.88 | 2019-2024 | |
| Urogen Pharma, INC. | $341.19 | 2021-2025 | Jelmyto |
| Astellas Pharma US INC | $313.63 | 2019-2024 | Myrbetriq, Veozah |
| Boston Scientific Corporation | $279.67 | 2021-2025 | Rezum Generator, Lithovue, General - Erectile Dysfunction |
| Procept Biorobotics Corporation | $236.88 | 2022-2025 | Aquabeam System |
| Bayer Healthcare Pharmaceuticals INC. | $233.93 | 2019-2025 | |
| Allergan, INC. | $190.57 | 2019-2022 | |
| C. R. Bard, INC. & Subsidiaries | $116.01 | 2025 | Bard Urinary Drainage Bag |
| Janssen Biotech, INC. | $106.14 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $101.86 | 2023-2025 | Gemtesa |
| Pfizer INC. | $94.99 | 2020-2025 | |
| Teleflex LLC | $73.36 | 2023-2025 | Urolift |
| Tolmar, INC. | $72.83 | 2023-2024 | |
| Ferring Pharmaceuticals INC. | $71.60 | 2019-2025 | Adstiladrin |
| Olympus America INC. | $64.92 | 2024-2025 | Tecoflex, Olympus, Olympus |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $63.18 | 2019-2025 | Resonance, Cook |
| Dornier Medtech America, INC | $54.81 | 2019 | |
| Dentsply Ih Ab | $54.49 | 2024-2025 | Lofric |
| Urovant Sciences INC | $54.04 | 2022 | |
| 180 Medical, INC. | $52.94 | 2023 | |
| Laborie Medical Technologies Corp. | $50.25 | 2021-2024 | Endosheath Technology |
| Neotract INC. | $49.50 | 2019-2020 | |
| Photocure INC | $49.37 | 2023-2025 | Cysview |
| Antares Pharma, INC. | $47.10 | 2024-2025 | Xyosted |
| Blue Earth Diagnostics | $40.88 | 2019-2022 | |
| Endo Pharmaceuticals INC. | $30.34 | 2020-2024 | Xiaflex |
| Tolmar Pharmaceuticals, INC. | $26.02 | 2019 | |
| Dendreon Pharmaceuticals LLC | $25.53 | 2019 | |
| Medtronic, INC. | $23.62 | 2024 | Ligasure |
| Agiliti Surgical, INC. | $23.62 | 2025 | Sonablate Hifu, Quanta System Fiber Dust Tfl Laser, Boston Scientific Lumenis Pulse 120h Holmium Laser W/ Moses Technology |
| Merck Sharp & Dohme LLC | $22.60 | 2022 | |
| Rochester Medical Corporation | $19.97 | 2019 | |
| Abc Home Medical Supply, INC. | $18.77 | 2025 | |
| Ambu INC. | $18.61 | 2025 | |
| Axonics, INC. | $16.73 | 2024 | Bulkamid, Axonics |
| Endo USA, INC. | $14.25 | 2024 | Aveed, Xiaflex |
| Amgen INC. | $12.42 | 2021 | |
| Coloplast Corp | $11.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John House listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.